Efficacy News and Research

RSS
XenoPort to present XP23829 preclinical data at ECTRIMS meeting

XenoPort to present XP23829 preclinical data at ECTRIMS meeting

Study finds wide variability in use of blood transfusions for coronary artery bypass graft surgery

Study finds wide variability in use of blood transfusions for coronary artery bypass graft surgery

Researchers investigate statin drugs to treat lung disease

Researchers investigate statin drugs to treat lung disease

Pharmalink's Nefecon for IgA nephropathy receives FDA orphan drug designation

Pharmalink's Nefecon for IgA nephropathy receives FDA orphan drug designation

Buprenorphine implant decreases opioid usage in persons with opioid dependence

Buprenorphine implant decreases opioid usage in persons with opioid dependence

Pycnogenol effective in relieving tinnitus symptoms: Study

Pycnogenol effective in relieving tinnitus symptoms: Study

Imprime PGG and cetuximab increase overall response rate in metastatic colorectal cancer

Imprime PGG and cetuximab increase overall response rate in metastatic colorectal cancer

Threshold announces TH-302 Phase 1/2 clinical trial interim results

Threshold announces TH-302 Phase 1/2 clinical trial interim results

Kennedy Krieger Institute launches phase II clinical trial to investigate Revatio for DMD treatment

Kennedy Krieger Institute launches phase II clinical trial to investigate Revatio for DMD treatment

US Oncology enrolls 1,000th patient in Phase I clinical trial

US Oncology enrolls 1,000th patient in Phase I clinical trial

Alkermes' VIVITROL medication for treatment of opioid dependence

Alkermes' VIVITROL medication for treatment of opioid dependence

FDA approves Vivitrol for treatment of opioid-dependent patients

FDA approves Vivitrol for treatment of opioid-dependent patients

Smart for Life(R) to add Lepticore(R) to product line

Smart for Life(R) to add Lepticore(R) to product line

Alimera to present Iluvien Phase 3 clinical trial data at AAO annual meeting

Alimera to present Iluvien Phase 3 clinical trial data at AAO annual meeting

EMA approves TWYNSTA therapy that reduces BP in hypertensive patients

EMA approves TWYNSTA therapy that reduces BP in hypertensive patients

Older people who do not get vaccinated rely on indigenous health practices

Older people who do not get vaccinated rely on indigenous health practices

First presentation of anti-HER2 antibody-drug conjugate as first-line therapy for advanced breast cancer

First presentation of anti-HER2 antibody-drug conjugate as first-line therapy for advanced breast cancer

Albireo reports positive results from A3309 Phase IIb study in chronic idiopathic constipation

Albireo reports positive results from A3309 Phase IIb study in chronic idiopathic constipation

Helix completes GLP toxicology study milestone in L-DOS47 development program

Helix completes GLP toxicology study milestone in L-DOS47 development program

Essentialis receives patent for active component in DCCR product

Essentialis receives patent for active component in DCCR product

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.